BioCentury
ARTICLE | Company News

AVI BioPharma, Medtronic deal

July 5, 2004 7:00 AM UTC

The parties ended their 2001 deal for MDT to develop AVII's Resten-NG cardiovascular therapy for stent and catheter delivery. In 2003, AVII exercised its option to convert MDT's license to Resten-NG t...